SR One News

BY CATEGORY: ALL / NOTABLE / CLINICAL IMPACT / NEW INVESTMENTS / FINANCING AND PARTNERSHIPS / PEOPLE

BY YEAR: 2023 / 2022 / 2021 / 2020

Palleon Pharmaceuticals raises $100M Series B

Frances Benson 9/17/20 Frances Benson 9/17/20

Palleon Pharmaceuticals raises $100M Series B

Read More

Early interim data from Trident-1, a registrational Phase 2 of Repotrectinib

Frances Benson 8/19/20 Frances Benson 8/19/20

Early interim data from Trident-1, a registrational Phase 2 of Repotrectinib

Read More

Principia Biopharma acquired by Sanofi for $3.7BN

Frances Benson 8/17/20 Frances Benson 8/17/20

Principia Biopharma acquired by Sanofi for $3.7BN

Read More

Pandion Therapeutics prices $135M IPO

Frances Benson 7/16/20 Frances Benson 7/16/20

Pandion Therapeutics prices $135M IPO

Read More

Nkarta Therapeutics prices $290M IPO

Frances Benson 7/10/20 Frances Benson 7/10/20

Nkarta Therapeutics prices $290M IPO

Read More

Tranquis Therapeutics raises $30M Series A

Frances Benson 7/9/20 Frances Benson 7/9/20

Tranquis Therapeutics raises $30M Series A

Read More

Mission Therapeutics raises $15M

Frances Benson 7/6/20 Frances Benson 7/6/20

Mission Therapeutics raises $15M

Read More

CRISPR Therapeutics raises $450M

Frances Benson 6/30/20 Frances Benson 6/30/20

CRISPR Therapeutics raises $450M

Read More

Frances Benson 5/29/20 Frances Benson 5/29/20

Tomivosertib demonstrates positive Phase 2 results in combination with checkpoint inhibitors for NSCLC patients

Read More

HotSpot Therapeutics raises $65M Series B

Frances Benson 5/21/20 Frances Benson 5/21/20

HotSpot Therapeutics raises $65M Series B

Read More

Pandion Therapeutics appoints John Sundy as CMO

Frances Benson 5/19/20 Frances Benson 5/19/20

Pandion Therapeutics appoints John Sundy as CMO

Read More

Second Genome and Gilead Sciences announce strategic collaboration

Frances Benson 4/6/20 Frances Benson 4/6/20

Second Genome and Gilead Sciences announce strategic collaboration

Read More

Pandion Therapeutics raises $80M Series B

Frances Benson 4/1/20 Frances Benson 4/1/20

Pandion Therapeutics raises $80M Series B

Read More

Design Therapeutics raises $45M Series A

Frances Benson 3/20/20 Frances Benson 3/20/20

Design Therapeutics raises $45M Series A

Read More

PsiOxus Therapeutics appoints Dr. Tom Lillie as CMO

Frances Benson 3/5/20 Frances Benson 3/5/20

PsiOxus Therapeutics appoints Dr. Tom Lillie as CMO

Read More

FDA approves TEPEZZA™ for the treatment of Thyroid Eye Disease

Frances Benson 1/20/20 Frances Benson 1/20/20

FDA approves TEPEZZA™ for the treatment of Thyroid Eye Disease

Read More